Sakar Healthcare Ltd
Pharmaceuticals & Biotechnology | Small Cap
Sakar Healthcare Ltd demonstrates a mixed financial performance. The company shows strong growth in revenue and operating profit, alongside a good asset growth rate, signalling positive business expansion. Profitability metrics such as gross profit margin, return on assets, and operating margin are reasonably healthy. However, liquidity is a significant area of concern, as indicated by poor current, quick, and cash ratios. The company's solvency appears strong due to high equity and minimal debt. Efficiency in utilizing assets is also weak. The company's growth trajectory is promising, but it needs to address its liquidity and efficiency challenges to ensure sustained financial stability and overall health.
Latest Report
View AllLatest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
- Valuation MetricsHighly Overvalued
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio8.00
- Financial Ratio4.00
- Profitability Ratio7.20
- Efficiency Ratio4.67
- Coverage Ratio5.60
- Solvency Ratio10.00
- Liquidity Ratio2.00
- Peer Assessment
- Management AssessmentBalanced
- Risk AssessmentBalanced
- 1 HourNeutral
- 2 HoursBearish
- 4 HoursNeutral
- 1 DayNeutral
- 1 WeekBullish
- 1 MonthBullish
Sakar Healthcare Ltd demonstrates a mixed financial performance. The company shows strong growth in revenue and operating profit, alongside a good asset growth rate, signalling positive business expansion. Profitability metrics such as gross profit margin, return on assets, and operating margin are reasonably healthy. However, liquidity is a significant area of concern, as indicated by poor current, quick, and cash ratios. The company's solvency appears strong due to high equity and minimal debt. Efficiency in utilizing assets is also weak. The company's growth trajectory is promising, but it needs to address its liquidity and efficiency challenges to ensure sustained financial stability and overall health.
Latest Report
View AllLatest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
Overall Valuation Score
P/E RATIO (TTM)
58.66
Industry Median
28.62
Small Cap Median
27.17
P/E RATIO
58.66
P/B RATIO
5.50
Industry Median
3.17
Small Cap Median
2.62
P/S RATIO
6.86
Industry Median
3.42
Small Cap Median
2.55
Others
PEG RATIO
2.64
EV/EBITDA RATIO
24.43
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹803.6 as on Jun 19, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
Quarterly Report⬤5th Feb 26
Quarterly Financial Results Q3 FY 2025-26
BULLISH SENTIMENT
The company exhibits strong growth trends, particularly in revenue and operating profit. This growth momentum suggests effective business strategies and market positioning. While net income growth is stagnant, the positive trends in revenue, operating profit, and asset growth indicate a promising outlook. Sustaining this growth trajectory will depend on continued innovation and strategic investments.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 34.74 | 3.91 | 15.04 | 16.34 | 41.57 |
| Operating Profit Growth Rate | 26.09 | 13.79 | 15.15 | 31.58 | 38 |
| Earnings Per Share (EPS) Growth | 30.12 | -24.72 | -19.85 | 48.42 | 71.89 |
| Asset Growth Rate | 50.56 | 25.37 | 15.77 | 6.68 | 15.9 |
| Net Income Growth Rate | 36.36 | -13.33 | -7.69 | 50 | 66.67 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
The company's financial ratios reveal a mixed performance. Cash earnings per share are positive, but adjusted earnings per share, book value per share and dividend per share are not good. The company is making capital expenditure, which is good sign of growth. Enhancing these financial metrics will be essential for attracting investment and ensuring long-term sustainability.
| Financial Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | 8.82 | 6.84 | 5.45 | 8.18 | 13.64 |
| Cash Earnings Per Share (Cash EPS) | 14.71 | 14.74 | 13.64 | 17.73 | 24.55 |
| Book Value Per Share | 74.71 | 91.05 | 119.55 | 130 | 147.27 |
| Dividend Per Share (DPS) | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures (CapEx) | 97.5 | 82.2 | 59.6 | 32.3 | 28.4 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
The company demonstrates strong profitability, driven by healthy gross profit margins, return on assets, and operating margins. However, return on equity and net margin are not good. The company is effectively managing its operations to generate profits. Focusing on these areas will solidify its financial performance and market position.
| Profitability Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Profit Margin | 14.84 | 13.53 | 13.07 | 16.29 | 17.86 |
| Return on Capital Employed (ROCE) | 12 | 9 | 7 | 9 | 13 |
| Return on Equity (ROE) | 11.81 | 7.51 | 4.56 | 6.29 | 9.26 |
| Return on Assets (ROA) | 10.82 | 9.82 | 9.77 | 12.05 | 14.35 |
| Operating Margin | 22.66 | 24.81 | 24.84 | 28.09 | 27.38 |
| Net Margin | 11.72 | 9.77 | 7.84 | 10.11 | 11.9 |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
The company's efficiency in utilizing its assets is mixed. While the days sales in inventory and receivable days are well-managed, Fixed asset turnover ratio, Inventory turnover ratio, Receivables turnover ratio and Capital turnover ratio indicates potential inefficiencies in asset utilization. Optimizing asset management can improve profitability and overall financial performance. Focusing on these areas can enhance the company's competitive position.
| Efficiency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Fixed Asset Turnover Ratio | 0.62 | 0.5 | 0.49 | 0.58 | 0.77 |
| Inventory Turnover Ratio | 7.27 | 7.93 | 6.19 | 4.14 | 3.63 |
| Receivables Turnover Ratio | 9.85 | 7.39 | 7.12 | 6.85 | 6.22 |
| Days Sales in Inventory Ratio | 50.21 | 46.03 | 58.97 | 88.16 | 100.55 |
| Receivable Days | 37.06 | 49.39 | 51.26 | 53.28 | 58.68 |
| Capital Turnover Ratio | 0.59 | 0.48 | 0.47 | 0.51 | 0.71 |
Fixed Asset Turnover Ratio
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
Capital Turnover Ratio
The company's coverage ratios present a mixed picture. While the interest coverage ratio is adequate, the lack of equity dividend coverage raises concerns. The ability to comfortably cover interest expenses is a positive sign, but the absence of dividend coverage may disappoint investors seeking regular income. Addressing this gap could enhance investor relations and overall financial attractiveness.
| Coverage Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Interest Coverage Ratio | 7.33 | 3.83 | 3 | 3.44 | 6 |
| Equity Dividend Coverage Ratio |
Interest Coverage Ratio
Equity Dividend Coverage Ratio
The company exhibits strong solvency, characterized by minimal debt and a high equity base. This provides a solid foundation for long-term financial stability and growth. The low debt levels reduce financial risk and provide flexibility for future investments. This stability can enhance investor confidence and support sustainable business development.
| Solvency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debt Ratio | 0.41 | 0.38 | 0.2 | 0.19 | 0.09 |
| Debt to Equity Ratio | 0.69 | 0.61 | 0.25 | 0.23 | 0.1 |
| Equity Ratio | 0.59 | 0.62 | 0.8 | 0.81 | 0.91 |
| Debt To Asset Ratio | 0.33 | 0.32 | 0.17 | 0.16 | 0.07 |
Debt Ratio
Debt to Equity Ratio
Equity Ratio
Debt To Asset Ratio
The company's liquidity position is weak, suggesting potential difficulties in meeting short-term obligations. While maintaining low debt levels is beneficial, the lack of liquid assets raises concerns about financial flexibility. This situation may hinder the company's ability to capitalize on immediate growth opportunities or manage unexpected expenses. Improving current and quick ratios is essential for ensuring operational stability.
| Liquidity Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Current Ratio | 1.07 | 1.05 | 1.22 | 1.4 | 1.21 |
| Quick Ratio | 0.8 | 0.79 | 0.76 | 0.71 | 0.65 |
| Cash Ratio | 0 | 0 | 0 | 0 | 0 |
| Operating Cash Flow Ratio | 0.7 | 0.58 | 0.39 | 0.53 | 0.39 |
Current Ratio
Quick Ratio
Cash Ratio
Operating Cash Flow Ratio
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Accent Microcell Ltd | 7.96 | 24.25 | Neutral | 57.00 | 18.28 | 44.00 |
| 2 | Lincoln Pharmaceuticals Ltd | 7.31 | 14.01 | Neutral | 98.00 | 43.88 | 88.00 |
| 3 | NGL Fine Chem Ltd | 6.98 | 39.22 | Overvalued | 73.00 | 67.39 | 48.00 |
| 4 | Medico Remedies Ltd | 6.61 | 37.70 | Overvalued | 17.00 | 1.58 | 13.00 |
| 5 | Kilitch Drugs (India) Ltd | 6.61 | 21.54 | Neutral | 37.00 | 9.27 | 30.00 |
| 6 | Kopran Ltd | 6.60 | 25.82 | Neutral | 62.00 | 6.30 | 26.00 |
| 7 | SMS Lifesciences India Ltd | 6.59 | 21.20 | Undervalued | 45.00 | 70.68 | 19.00 |
| 8 | Infinium Pharmachem Ltd | 6.42 | 26.90 | Neutral | 22.00 | 6.43 | 14.00 |
| 9 | Sakar Healthcare Ltd | 5.81 | 58.66 | Highly Overvalued | 69.00 | 13.70 | 30.00 |
| 10 | Medicamen Biotech Ltd | 5.73 | 32.19 | Neutral | 20.00 | 6.94 | 10.00 |
| 11 | Albert David Ltd | 5.63 | -272.47 | Neutral | 5.00 | -2.62 | -1.00 |
| 12 | Zim Laboratories Ltd | 5.41 | 41.96 | Neutral | 30.00 | 1.11 | 6.00 |
| 13 | Remus Pharmaceuticals Ltd | 5.31 | 25.48 | Neutral | 57.00 | 20.97 | 46.00 |
| 14 | Ind-Swift Laboratories Ltd | 4.95 | 39.28 | Neutral | 45.00 | 4.89 | 41.00 |
| 15 | Venus Remedies Ltd | 4.83 | 23.37 | Neutral | 147.00 | 74.30 | 103.00 |
| 16 | Wanbury Ltd | 4.65 | 28.62 | Neutral | 88.00 | 18.93 | 43.00 |
| 17 | Nectar Lifescience Ltd | 3.83 | -2.67 | Neutral | -59.00 | -2.95 | -293.00 |
Sakar Healthcare's management shows mixed effectiveness. Consistent sales growth and improved operating profit margins signal operational strengths. However, declining promoter holding and increased borrowings raise concerns about financial management. While recent profitability has improved, the overall financial stability requires close scrutiny.
| Category | Metric | Value | Assessment |
|---|---|---|---|
| PROS | Sales Growth | 16% | Strong compounded sales growth (5Y) indicates a positive trend. |
| OPM | 31.29% | Improving OPM % (Mar 2025) shows better operational efficiency. | |
| CONS | Promoter Holding | 53.58% | Declining promoter holding raises concerns about confidence. |
| Debt/Equity Ratio | Increased Borrowings | Increase in borrowings indicates increased risk. |
Financial Performance & Growth
Sakar Healthcare's financial growth shows mixed performance. Sales growth has been consistently positive, while profit growth has been more volatile. Recent trends show improvement, but historical data indicates inconsistencies.
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Sales Growth (%) | - | 14.16% | 35.34% | 4.01% | 14.98% | 15.82% |
| Operating Profit (₹ Cr) | 20 | 23 | 29 | 33 | 38 | 50 |
| Net Profit (₹ Cr) | 10 | 11 | 15 | 13 | 12 | 18 |
Capital Efficiency & Returns
Capital efficiency and returns for Sakar Healthcare are weak. The ROCE is relatively low compared to its peers, indicating that the company is not generating high returns from its capital. The Cash Conversion Cycle has fluctuated significantly, suggesting inconsistency in working capital management.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| ROCE (%) | 13% | 12% | 9% | 7% | 9% |
| Cash Conversion Cycle (Days) | 19 | -39 | 7 | 51 | 163 |
Financial Health & Prudence
Sakar Healthcare's financial health presents a mixed picture. While the company has increased its sales, it has also increased its borrowings, leading to a higher debt-to-equity ratio. The dividend payout is consistently at 0%.
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Borrowings (₹ Cr) | 17 | 43 | 93 | 119 | 79 | 75 |
Shareholding & Ownership Structure
The shareholding structure of Sakar Healthcare indicates concerning trends. The promoter holding has decreased significantly over the years, which could signal a lack of confidence from the company's leadership.
| Metric | Mar 2017 | Mar 2020 | Mar 2023 | Mar 2025 |
|---|---|---|---|---|
| Promoter Holding (%) | 68.61% | 72.88% | 60.72% | 53.58% |
Sakar Healthcare presents a moderate risk profile. The company's increasing debt and fluctuating cash conversion cycle raise concerns about financial stability and operational efficiency. The decline in promoter holding further contributes to the risk. While sales growth and OPM show positive trends, the underlying financial health needs careful monitoring.
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10804.48Bullish
- SMA 20806.93Bearish
- SMA 50821.17Bearish
- EMA 10805.30Bearish
- EMA 20808.55Bearish
- EMA 50813.95Bearish
- DEMA 10803.65Bullish
- DEMA 20801.72Bullish
- DEMA 50812.93Bearish
- TEMA 10805.89Bearish
- TEMA 20800.37Bullish
- TEMA 50802.63Bullish
- MACD-4.75Bullish
- ADX15.63Weak Trend
- IndicatorValueSignal
- RSI45.62Neutral
- CCI-22.12Neutral
- ROC 90.57Bullish
- ROC 140.90Bullish
- ROC 25-3.07Bearish
- Stoch K56.34Neutral
- Stoch D53.70Neutral
- IndicatorValueSignal
- BB Upper828.49Neutral
- BB Middle806.93Neutral
- BB Lower785.37Neutral
- ATR12.62Low Volatility
- IndicatorValueSignal
- MFI56.54Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10802.83Bullish
- SMA 20817.94Bearish
- SMA 50813.56Bearish
- EMA 10807.07Bearish
- EMA 20811.75Bearish
- EMA 50808.77Bearish
- DEMA 10801.79Bullish
- DEMA 20806.24Bearish
- DEMA 50828.26Bearish
- TEMA 10802.35Bullish
- TEMA 20799.92Bullish
- TEMA 50810.64Bearish
- MACD-4.66Bearish
- ADX20.61Weak Trend
- IndicatorValueSignal
- RSI45.36Neutral
- CCI-59.88Neutral
- ROC 9-1.26Bearish
- ROC 14-3.45Bearish
- ROC 25-0.42Bearish
- Stoch K33.69Neutral
- Stoch D27.07Neutral
- IndicatorValueSignal
- BB Upper851.47Neutral
- BB Middle817.94Neutral
- BB Lower784.41Neutral
- ATR18.48Low Volatility
- IndicatorValueSignal
- MFI41.90Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10816.23Bearish
- SMA 20815.10Bearish
- SMA 50799.54Bullish
- EMA 10810.64Bearish
- EMA 20811.11Bearish
- EMA 50778.16Bullish
- DEMA 10805.15Bearish
- DEMA 20819.27Bearish
- DEMA 50846.12Bearish
- TEMA 10799.59Bullish
- TEMA 20804.67Bearish
- TEMA 50N/AN/A
- MACD4.37Bearish
- ADX30.24Strong Trend
- IndicatorValueSignal
- RSI49.43Neutral
- CCI-44.74Neutral
- ROC 9-4.21Bearish
- ROC 14-4.22Bearish
- ROC 250.09Bullish
- Stoch K19.14Oversold
- Stoch D18.23Oversold
- IndicatorValueSignal
- BB Upper859.00Neutral
- BB Middle815.10Neutral
- BB Lower771.21Neutral
- ATR31.71Low Volatility
- IndicatorValueSignal
- MFI55.18Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10808.49Bearish
- SMA 20805.17Bearish
- SMA 50693.93Bullish
- SMA 100587.88Bullish
- SMA 200481.65Bullish
- EMA 10808.75Bearish
- EMA 20787.52Bullish
- EMA 50709.45Bullish
- EMA 100621.40Bullish
- EMA 200526.09Bullish
- DEMA 10818.72Bearish
- DEMA 20838.62Bearish
- DEMA 50820.33Bearish
- DEMA 100756.91Bullish
- DEMA 200658.24Bullish
- TEMA 10806.02Bearish
- TEMA 20830.12Bearish
- TEMA 50850.28Bearish
- TEMA 100816.09Bearish
- TEMA 200738.29Bullish
- MACD35.04Bearish
- ADX29.92Strong Trend
- IndicatorValueSignal
- RSI54.75Neutral
- CCI-43.56Neutral
- ROC 14-0.08Bearish
- ROC 2532.77Bullish
- Stoch K38.35Neutral
- Stoch D51.94Neutral
- IndicatorValueSignal
- BB Upper851.79Neutral
- BB Middle805.17Neutral
- BB Lower758.55Neutral
- ATR52.75Low Volatility
- IndicatorValueSignal
- MFI58.32Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
- IndicatorValueSignal
- SMA 20586.60Bullish
- SMA 50453.88Bullish
- EMA 20615.10Bullish
- EMA 50495.81Bullish
- DEMA 20738.44Bullish
- DEMA 50615.31Bullish
- TEMA 20788.94Bullish
- TEMA 50690.64Bullish
- MACD97.57Bullish
- ADX50.25Strong Trend
- IndicatorValueSignal
- RSI74.92Overbought
- CCI220.45Overbought
- ROC 1456.09Bullish
- ROC 2593.88Bullish
- Stoch K84.17Overbought
- Stoch D85.10Overbought
- IndicatorValueSignal
- BB Upper831.44Neutral
- BB Middle586.60Neutral
- BB Lower341.76Neutral
- ATR80.84High Volatility
- IndicatorValueSignal
- MFI90.82Overbought
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
- IndicatorValueSignal
- SMA 6536.32Bullish
- SMA 12444.90Bullish
- SMA 24367.48Bullish
- EMA 6577.08Bullish
- EMA 12485.15Bullish
- EMA 24409.05Bullish
- DEMA 6693.09Bullish
- DEMA 12596.87Bullish
- DEMA 24507.12Bullish
- TEMA 6743.77Bullish
- TEMA 12664.95Bullish
- TEMA 24554.98Bullish
- MACD93.70Bullish
- ADX34.79Strong Trend
- IndicatorValueSignal
- RSI77.63Overbought
- CCI344.91Overbought
- ROC 25127.15Bullish
- ROC 50489.35Bullish
- Stoch K65.44Neutral
- Stoch D43.26Neutral
- IndicatorValueSignal
- BB Upper646.87Overbought
- BB Middle378.00Neutral
- BB Lower109.13Neutral
- ATR99.28High Volatility
- IndicatorValueSignal
- MFI97.30Overbought